Baculovirus Expression System Market
完整報告名稱與涵蓋範圍
Baculovirus Expression System Market Size, Share & Trends Analysis Report By Product Type (Baculovirus, Expression Vector, Reagents, Others), By Application (Therapeutics, Vaccines, Protein Purification, Others), By End User (Biopharmaceutical Companies, Research Institutes, Others), By Region, And By Segment Forecasts, 2024-2031
報告摘要
With a 2023 valuation of USD 374.79 Mn, the global Baculovirus Expression System Market is anticipated to advance to USD 660.97 Mn by 2031, demonstrating a CAGR of 7.43% during the 2024–2031 forecast window.
Baculovirus Expression System encompasses The baculovirus vector system induces recombinant protein expression in insect cell cultures. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is underpinned by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Baculovirus Expression System Market Snapshot
Chapter 4. Global Baculovirus Expression System Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Baculovirus
5.2.2. Expression Vector
5.2.3. Reagents
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Therapeutics
6.2.2. Vaccines
6.2.3. Protein Purification
6.2.4. Others
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Biopharmaceutical Companies
7.2.2. Research Institutes
7.2.3. Others
Chapter 8. Baculovirus Expression System Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.1.2. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.3. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.1.4. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2024-2031
8.2.2. Europe Baculovirus Expression System Market revenue (US$ Million) By Application, 2024-2031
8.2.3. Europe Baculovirus Expression System Market revenue (US$ Million) By End User, 2024-2031
8.2.4. Europe Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2024-2031
8.3.2. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Application, 2024-2031
8.3.3. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By End User, 2024-2031
8.3.4. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
8.4.2. Latin America Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.4.3. Latin America Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
8.4.4. Latin America Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
8.5.4. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific,
9.2.2. Merck KGaA,
9.2.3. Takara Bio,
9.2.4. Agilent Technologies,
9.2.5. Oxford Expression Technologies,
9.2.6. Promega Corporation,
9.2.7. Qiagen N.V.,
9.2.8. Bio-Rad Laboratories,
9.2.9. New England Biolabs,
9.2.10. Genscript Biotech Corporation,
9.2.11. Syngene International Limited,
9.2.12. Sartorius AG,
9.2.13. Aragen Bioscience,
9.2.14. Vivopure,
9.2.15. Creative Biogene,
9.2.16. Absolute Antibody,
9.2.17. Rockland Immunochemicals,
9.2.18. Protein Technologies Inc.,
9.2.19. Proteogenix,
9.2.20. Virovek
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們